Medidata Blog

Sept. 15 Media Roundup

Reading Time: 3 minutes

Last week’s news had no shortage of exciting stories, which included promising medical and research innovations, the release of new Apple products and forward-thinking ideas released from mHealth tech companies.

Chief Operating Officer and tech evangelist Mike Capone was particularly interested in the big data technique developed by researchers at Rice University and its implications for the healthcare industry. “This article highlights something that Medidata has been emphasizing for a while -- the importance of advancing analytics and bringing real world data into clinical trials.”

Read up on all of the news coverage we shared last week plus the article Mike found notable below.

mHealth and Tech

Pharma and Life Sciences

  • Wouldn’t a universal flu vaccine be amazing news? Thanks to independent teams of scientists using a viral protein to ward off groups of viruses, we’re getting closer to one!
  • Our own Glen de Vries was quoted in an article about the increasingly difficult process of clinical trials and the need to improve efficiency by focusing on data.
  • The Lasker Awards were announced last week! One of the most respected awards in medicine, this year’s award went to three scientists for a cancer treatment and genetics discoveries
  • Silicon Valley “unicorn” Stemcentrx is fighting common cancer with a unique approach (that isn’t universally accepted yet) which includes targeting stem cells. 
  • Regeneron Pharmaceuticals is learning how to stop excessive bone growth of rare disease patients whose condition causes them to grow a second skeleton.
  • In England, the National Institute of Health Care and Excellence (NICE) approved a new immunotherapy drug for patients whose melanoma stopped responding to previous treatments.  
  • In a Clinical Leader article, Mike McKay talks about why he thinks RBM is the “biggest game changer to hit clinical operations since EDC.”
  • Researchers are testing gene therapy as a potential way to keep the immune system from attacking healthy, insulin-producing cells in the pancreas. Read all the details here.
  • In promising news for some leukemia patients, blood cells created in a lab to kill cancer have led to four-year remissions.

Company News

If you haven’t registered for our September 30 - October 1 conference presented with The New York Academy of Sciences, it’s not too late! Sign up today to attend the event and learn about the future potential for mobile health devices to transform clinical trials.

Jacob Angevine